17 Oct 2022
Asahi Kasei Pharma calls for applications for open innovation
By Staff Writer
Asahi Kasei Pharma, a subsidiary of the diversified Japanese multinational company Asahi Kasei, is publicly calling for new proposals for drug development research. The open innovation programme forms part of its efforts to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes and enterprises worldwide. The application period begins at 05:00 GMT...